The blueprint for cardiovascular MR in clinical use has existed since the 1980s, when pioneers like radiologist Dr. Charles Higgins and cardiologist Dr. Gerald Pohost recognized that MR could become a powerful instrument for cardiac imaging.
The blueprint for cardiovascular MR in clinical use has existed since the 1980s, when pioneers like radiologist Dr. Charles Higgins and cardiologist Dr. Gerald Pohost recognized that MR could become a powerful instrument for cardiac imaging.
They sought a versatile tool. While the diagnosis of coronary artery disease would be the rock on which cardiac MR imaging would be based, its applications would address many heart conditions.
The blueprint anticipated that cardiac MR would provide evaluations of congenital heart disease, cardiomyopathy, arrhythmogenic dysplasia, valvular disease, and pulmonary hypertension. Although they remained a dream for most of cardiac MR's history, MR-guided cardiac interventions have long been considered an important aspect of the modality's potential influence on cardiology.
Realizing these dreams has not been easy. Poor temporal resolution was a stumbling block until more powerful MR scanners, multichannel parallel image processing, and better pulse sequences were introduced. With those innovations at hand, researchers are now moving swiftly to build a set of applications based on the original blueprint.
The 2004 meeting of the Society for Cardiovascular Magnetic Resonance reflected that movement. The three-day conference in Barcelona, Spain, will be remembered for plenary sessions that delved into CMR's increasingly varied clinical utility and for scientific inquiries that are boosting the user-friendliness of proven clinical procedures. Highlights included:
Clinician interest in cardiovascular MR was reflected in a 19% increase in professional registration compared with the 2003 conference, according to scientific program director Dr. Stefan Neubauer. Of 909 physicians and technologists in attendance, slightly more than half were Europeans.
Seventy percent of physician registrants were cardiologists, and 30% were radiologists. Seven of 10 physicians who perform CMR in the field are cardiologists.
The quantity and quality of scientific exhibits improved, according to Neubauer. Despite new review criteria that resulted in a 30% rejection rate, nearly 1000 papers and posters were accepted.
"CMR has reached a level of maturity that was clearly unthinkable just a few years ago," Neubauer said.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.